FINWIRES · TerminalLIVE
FINWIRES

Xero表示,澳大利亚小型企业今年开局稳健。

By

-- Xero周四表示,澳大利亚小型企业今年开局强劲,3月份季度销售额增长7.2%,但中东冲突导致的燃油价格上涨构成主要风险。 根据Xero小型企业洞察数据,尽管澳大利亚央行两次上调现金利率,本季度业绩依然强劲,尤其是在最后两个月,而加息本可能对销售造成不利影响。本季度销售额、就业和工资均有所增长,几乎达到历史平均增长率。 该公司表示,燃油成本飙升导致的价格上涨目前尚未在小型企业中普遍发生,3月份的销售增长可能是由于实物销售增加而非价格上涨所致。 这一点体现在运输和物流行业的销售额增长了13.2%,该行业受燃油价格的影响最大。 该公司表示:“燃油价格高企的时间越长,澳大利亚储备银行为应对不断扩大的通胀冲击而进一步提高现金利率的风险就越大。” Xero补充说,这个依赖燃料进口的国家目前的燃料库存“充足”,并建议小型企业照常购买燃料。

Related Articles

Asia

Electro Optic Systems Reports Contract Backlog Growth as of March 31

Electro Optic Systems Holdings (ASX:EOS) reported a contract backlog of AU$518 million as of March 31, up 13% from the end of 2025, according to a Thursday filing with the Australian bourse.The company closed the March quarter with unrestricted cash holdings of AU$95.1 million, representing a decrease of AU$11.8 million from the end of 2025, per the filing.

$ASX:EOS
Asia

Regis Healthcare Expects Fiscal 2026 Underlying EBITDA at Top End of Guidance

Regis Healthcare (ASX:REG) said it expects fiscal 2026 underlying earnings before interest, taxes, depreciation, and amortization (EBITDA) of about AU$135 million, at the top end of guidance, according to a Thursday Australian bourse filing.Occupancy across mature homes averaged about 96% in the fiscal third quarter, per the filing.The company said it generated net refundable accommodation deposit (RAD) cash inflows of AU$44.5 million in the third quarter, taking the total net RAD cash inflows for the year to date to AU$223 million.As resident turnover occurs, the progressive repricing of existing paid-up RADs to current advertised room prices is expected to generate net operating cash inflows of about AU$400 million over time while also increasing RAD retention earnings, the company added.

$ASX:REG
Research

Research Alert: CFRA Keeps Hold Opinion On Shares Of Mondelez International

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price of $63, raised $1, reflects a 19x multiple of projected 2027 EPS, in line with MDLZ's historical forward P/E average. We raise our 2026 EPS estimate by $0.06 to $3.08, but cut 2027's by $0.11 to $3.32. We continue to see headwinds related to chocolate and biscuits divisions, though favorable forex has been helping to a degree. MDLZ highlighted plans to stimulate growth with more promotional activity, which could boost revenues (we see an acceleration in revenues in 2027), but may come with the trade-off of narrower margins. We note that cost-saving efforts can also contribute to staving off some of the margin pressure. MDLZ is largely hedged on its cocoa input costs for 2026 but less so in 2027. Thus, if the substantial rise in cocoa pricing in 2025 does not reemerge, it should help the bottom line in 2027 as cost pressures should ease. Share buybacks have also contributed to EPS, and we note that Q1 2026 share count was down 1.5% from one year earlier.

$MDLZ